Justin M. Watts

Also affiliated with Sylvester Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies”.

Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4054

N/A

1.4DataRank · unranked

48 citations

Helena G. Dos Santos, Deukwoo Kwon, Terrence Bradley, Amber Thomassen, Charles Y. Chen +9 more

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Leukemia(2023)10.1038/s41375-023-02050-4

N/A

0.982DataRank · unranked

52 citations

Maximilian Stahl, Justin Taylor, Xiaoli Mi, Namrata S. Chandhok, Justin M. Watts +11 more

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia(2021)10.1038/s41375-021-01328-9

N/A

0DataRank · unranked

183 citations

Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji +35 more

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.07.002

N/A

0DataRank · unranked

373 citations

Nicola Long, Anna Reister Schultz, Stephen E. Kurtz, Cristina E. Tognon, Kara Johnson +89 more

Molecular characteristics and outcomes in Hispanic and non‐Hispanic patients with acute myeloid leukemia

eJHaem(2022)10.1002/jha2.589

N/A

0DataRank · unranked

5 citations

Deukwoo Kwon, Jorge Monge, Mikkael A. Sekeres, Namrata S. Chandhok, Amber Thomassen +6 more

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients

Cancers(2022)10.3390/cancers14174094

N/A

0DataRank · unranked

3 citations

Hassan Al‐Ali, Claude‐Henry Volmar, Shaun P. Brothers, Justin M. Watts, Claes Wahlestedt +2 more

Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax

Blood(2023)10.1182/blood-2023-187861

N/A

0DataRank · unranked

5 citations

Joseph G. Jurcic, Maria R. Baer, William Blum, P. Brent Ferrell, Brian A. Jonas +7 more

Data from Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies

(2023)10.1158/1078-0432.c.6530669

N/A

0DataRank · unranked

0 citations

Helena G. Dos Santos, Deukwoo Kwon, Terrence Bradley, Amber Thomassen, Charles Chen +9 more

Data from Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies

(2023)10.1158/1078-0432.c.6530669.v1

N/A

0DataRank · unranked

0 citations

Helena G. Dos Santos, Deukwoo Kwon, Terrence Bradley, Amber Thomassen, Charles Chen +9 more

Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML

npj Precision Oncology(2025)10.1038/s41698-025-01013-5

N/A

0DataRank · unranked

2 citations

Tiffany Nong, Katarina Micin, Deborah Soong, Ellen Madarang, Maurizio Affer +10 more

Intercurrent presentation of hairy cell leukemia and diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis: a case report

Leukemia Research Reports(2025)10.1016/j.lrr.2025.100535

N/A

0DataRank · unranked

1 citations

Xiaoqiong Wang, Wenhui Li, Ellen Madarang, Justin M. Watts, Justin Taylor +1 more

Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged AML

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.13.681683

N/A

0DataRank · unranked

1 citations

Helena G. Dos Santos, Felipe Beckedorff, Tulasigeri M. Totiger, Adnan K. Mookhtiar, Anna Lesley Kingham +9 more

Adult leukemia in Florida 2010-2019: diverse, aging population as an indicator for the United States

Blood Neoplasia(2025)10.1016/j.bneo.2025.100078

N/A

0DataRank · unranked

0 citations

Rebecca Kaiser, Christopher Armstrong, David Bared Dukenik, Nancy S. Elliott, Raymond R. Balise +5 more

Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development

Cancers(2020)10.3390/cancers12113225

N/A

0DataRank · unranked

70 citations

Deborah Soong, Binbin Zheng-Lin, Justin M. Watts, Justin Taylor, Michele Stanchina

Balancing Activation and Repression: CoREST-p300 Antagonism Controls Retinoic Acid-Driven Differentiation in AML

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.13.682235

N/A

0DataRank · unranked

0 citations

Helena G. Dos Santos, Sadat Dokaneheifard, Samuel D. Whedon, M. Valencia-S., Arigela Harikumar +5 more

The Hi's and Lo's of Cytarabine in Acute Myeloid Leukemia

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0462

N/A

0DataRank · unranked

6 citations

Terrence Bradley, Justin M. Watts